If Walgreens Boots Alliance follows through with a sale to private equity, the company might join other healthcare deals ...

Walgreens surges amid buyout rumors with Sycamore Partners, but doubts remain on deal feasibility and long-term prospects.

Shares of Walgreens climbed 20% Tuesday after reports emerged that the company is in talks to sell itself to private equity ...

The pharmacy mega-giant shot up 18% on Tuesday following The Wall Street Journal's report, raising the company's value by ...

Walgreens has struggled lately due to declining prescription reimbursements and rising competition from Amazon and other ...

Financial writer's analysis on the potential sale of Walgreens to Sycamore Partners, highlighting challenges with debt and ...

Walgreens will have more freedom to aggressively cut costs if it becomes privately owned, one industry analyst said. The company is reportedly in talks with Sycamore Partners.

Following the report, shares of the pharmacy giant jumped 18%, the largest one-day boost in Walgreens' history.

Selling to private equity would give the pharmacy chain the leniency needed to execute an aggressive turnaround. Workers and ...

Walgreens retreated 3.26% to $10.08 in Wednesday's pre-market trading, following Tuesday's 20% surge, as prominent market ...

Walgreens Boots Alliance is in talks to sell itself to Sycamore Partners, a private-equity firm, in a strategic move of going private after years of declining stock performance.

Pharmaceutical retailer Walgreens explores potential acquisition deal with private equity firm Sycamore Partners.